Gene · 1785
Papers3,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data. | Front Oncol | 2023 | 38023180 | PubTator, text mining | PubMed |
| Progress in cancer neuroscience. | MedComm (2020) | 2023 | 38020711 | PubTator, text mining | PubMed |
| [The dynamin-2-gene related centronuclear myopathy]. | Med Sci (Paris) | 2023 | 37975763 | PubTator, text mining | PubMed |
| Porcine deltacoronavirus enters ST cells by clathrin-mediated endocytosis and does not require Rab5, Rab7, or Rab11. | Microbiol Spectr | 2023 | 37962380 | PubTator, text mining | PubMed |
| SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances. | Front Oncol | 2023 | 37909026 | PubTator, text mining | PubMed |
| The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis. | Biomolecules | 2023 | 37892232 | PubTator, text mining | PubMed |
| The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV. | mBio | 2023 | 37882563 | PubTator, text mining | PubMed |
| Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives. | F1000Res | 2023 | 37868300 | PubTator, text mining | PubMed |
| Novel Alzheimer's disease genes and epistasis identified using machine learning GWAS platform. | Sci Rep | 2023 | 37848535 | PubTator, text mining | PubMed |
| Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma. | Biochem Biophys Res Commun | 2023 | 37844446 | PubTator, text mining | PubMed |
| Dynamin-dependent entry of Chlamydia trachomatis is sequentially regulated by the effectors TarP and TmeA. | Res Sq | 2023 | 37841835 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Multifaceted functions of Drp1 in hypoxia/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy. | Mil Med Res | 2023 | 37833768 | PubTator, text mining | PubMed |
| PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. | Front Immunol | 2023 | 37818357 | PubTator, text mining | PubMed |
| P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation. | Signal Transduct Target Ther | 2023 | 37806990 | PubTator, text mining | PubMed |
| Cell-specific secretory granule sorting mechanisms: the role of MAGEL2 and retromer in hypothalamic regulated secretion. | Front Cell Dev Biol | 2023 | 37799273 | PubTator, text mining | PubMed |
| Mutations in the histone methyltransferase Ezh2 drive context-dependent leukemia in Xenopus tropicalis. | Leukemia | 2023 | 37794102 | PubTator, text mining | PubMed |
| Targeting of insulin receptor endocytosis as a treatment to insulin resistance. | J Diabetes Complications | 2023 | 37788593 | PubTator, text mining | PubMed |
| The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications. | Cells | 2023 | 37759535 | PubTator, text mining | PubMed |
| Mutational screening of Greek patients with axonal Charcot-Marie-Tooth disease using targeted next-generation sequencing: Clinical and molecular spectrum delineation. | J Peripher Nerv Syst | 2023 | 37747677 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1785/papers?page=7